DDC and Parkinson disease: AAV2-aromatic L-amino acid decarboxylase (AADC) received through CED resulted in stable 3-fold 18F-fluoro-L-dopa PET signals while maintaining Unified Parkinson’s Disease Rating Scale (UPDRS) improvements during a 60-month observation period [97].